Practice Economics

Retiring Baby Boomers leave fewer workers to pay for Medicare


 

References

The influx of aging Baby Boomers into the ranks of the retired will reduce the ratio of workers available to pay for each Medicare part A beneficiary by 40% from 2000 to 2030, according to the 2016 report of the Medicare Trustees.

In 2015, there were 3.1 workers for each part A beneficiary, putting the United States in the middle of a projected drop from 4.0 workers per beneficiary in 2000 down to 2.4 in 2030. The Boomer-induced drop will largely be over by then, but the decline will continue until there are about 2.1 workers for each part A beneficiary by 2090, the report said.

“This reduction implies an increase in the [Medicare part A] cost rate of about 50% by 2090, relative to its current level, solely due to this demographic factor,” the trustees noted.

The projections are done using three sets – low-cost, intermediate, and high-cost – of economic and demographic assumptions. The figures presented here are from the intermediate assumption.

rfranki@frontlinemedcom.com

Recommended Reading

House Republicans unveil long-awaited plan to replace health law
MDedge Hematology and Oncology
Supreme Court deadlocks on immigration policy case
MDedge Hematology and Oncology
Implementation of ipilimumab therapy in a private practice oncology group: overcoming start-up and reimbursement issues related to expensive new cancer drugs
MDedge Hematology and Oncology
Nearly 200 practices expected to participate in Oncology Care Model
MDedge Hematology and Oncology
Dr. Richard Pazdur named acting director of FDA’s Oncology Center of Excellence
MDedge Hematology and Oncology
Multisite NIH-sponsored research can now use single IRB
MDedge Hematology and Oncology
Little evidence of ‘slippery slope’ with euthanasia or physician-assisted suicide
MDedge Hematology and Oncology
Medical errors and the law
MDedge Hematology and Oncology
Docs to CMS: MACRA is too complex and should be delayed
MDedge Hematology and Oncology
Lack of hematology-specific measures not barrier to quality end of life care
MDedge Hematology and Oncology